EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Association between depression and low skeletal muscle mass in patients with newly diagnosed lung cancer

Zeynep Alaca Topcu, Ismail Yurtsever, Zehra Sucuoglu Isleyen, Mehmet Besiroglu, Atakan Topcu, Ayse Irem Yasin, Abdallah Tm Shbair, Melih Simsek, Mesut Seker, Mahmut Gumus, Haci Mehmet Turk

Frontiers in Psychology · 29.05.2026 · 17

DOI: 10.3389/fpsyg.2026.1829410 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Psychology, online erschienen am 29.05.2026. Verfasst von Zeynep Alaca Topcu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Istanbul Medeniyet University Göztepe Prof. Dr. Süleyman Yalçın City Hospital, Istanbul, Türkiye. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Depression and reduced muscle mass are common in patients with lung cancer, and both are associated with adverse clinical outcomes. However, data examining their interrelationship remain limited. Materials and methods This cross-sectional study included 100 patients with newly diagnosed lung cancer undergoing systemic therapy. Depressive symptoms were assessed using the Beck Depression Inventory (BDI). Skeletal muscle mass was evaluated using computed tomography (CT)-derived skeletal muscle index (SMI) at the L3 vertebral level. Clinical and demographic variables were analyzed for associations with depression.

Results

Clinically relevant depressive symptoms were identified in 71% of patients, and CT-defined low skeletal muscle mass (LSMM) was present in 67% of patients. Scores on BDI were significantly and inversely correlated with total muscle area (TMA; r = −0.418, p < 0.001) and skeletal muscle index ( r = −0.358, p < 0.001). In age-adjusted multivariate analysis, low SMI (OR 3.05, 95% CI 1.15–8.09) and higher Charlson Comorbidity Index (CCI) values (OR 3.27, 95% CI 1.25–8.68) were independently associated with depression.

Conclusion

Depressive symptoms are highly prevalent in lung cancer and are independently associated with CT-defined LSMM and a higher comorbidity burden. Routine assessment of SMI on staging CT scans may help identify patients at increased risk and support early multidisciplinary interventions.

Schlagwörter

Stichwörter der Autor:innen

Beck Depression InventoryCharlson Comorbidity Indexdepressionlung cancersarcopeniaskeletal mass indexskeletal muscle mass

Autor:innen und Institutionen

  • Department of Medical Oncology, Istanbul Medeniyet University Göztepe Prof. Dr. Süleyman Yalçın City Hospital, Istanbul, Türkiye.
  • Department of Radiology, Bezmialem Vakif University Hospital, Istanbul, Türkiye.
  • Department of Medical Oncology, Bezmialem Vakif University Hospital, Istanbul, Türkiye.

Zitieren

APA

Alaca Topcu, Z., Yurtsever, I., Sucuoglu Isleyen, Z., Besiroglu, M., Topcu, A., Yasin, A. I., Shbair, A. T., Simsek, M., Seker, M., Gumus, M., & Turk, H. M. (2026). Association between depression and low skeletal muscle mass in patients with newly diagnosed lung cancer. Frontiers in Psychology, 17. https://doi.org/10.3389/fpsyg.2026.1829410

Vancouver

Alaca Topcu Z, Yurtsever I, Sucuoglu Isleyen Z, Besiroglu M, Topcu A, Yasin AI, et al. Association between depression and low skeletal muscle mass in patients with newly diagnosed lung cancer. Frontiers in Psychology. 2026;17. doi:10.3389/fpsyg.2026.1829410

BibTeX
@article{AlacaTopcu2026,
  author = {Alaca Topcu, Zeynep and Yurtsever, Ismail and Sucuoglu Isleyen, Zehra and Besiroglu, Mehmet and Topcu, Atakan and Yasin, Ayse Irem and Shbair, Abdallah Tm and Simsek, Melih and Seker, Mesut and Gumus, Mahmut and Turk, Haci Mehmet},
  title = {Association between depression and low skeletal muscle mass in patients with newly diagnosed lung cancer},
  journal = {Frontiers in Psychology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fpsyg.2026.1829410}
}
Kostenlos starten →